Literature DB >> 30182367

A comparison study of the transoral and bilateral axillo-breast approaches in robotic thyroidectomy.

Wan Wook Kim1,2, Jeeyeon Lee1, Jin Hyang Jung1, Ho Yong Park1, Ralph P Tufano2, Hoon Yub Kim3.   

Abstract

OBJECTIVES: Transoral robotic thyroidectomy (TORT) is a new remote access approach to avoid cervical incision. The purpose of this study is to compare two approaches used to avoid cervical incision: transoral approach and bilateral axillo-breast approach (BABA) in robotic thyroidectomy.
METHODS: A total of 90 patients were enrolled prospectively between September 2016 and April 2017. The BABA group had 43 and the TORT group had 47 patients, respectively. Parameters including clinicopathologic data, operative time, complications, laboratory data, hospital stay, postoperative pain, and cosmetic satisfaction were analyzed.
RESULTS: Complications were not different among the two groups. The operative time of TORT was longer than BABA until 15 cases of TORT were completed, but there was no difference after that. The Visual Analogue Scale score in TORT was lower than BABA in all the periods. TORT showed a higher cosmetic satisfaction after surgery. There was no infection or permanent mental nerve hypoesthesia in TORT.
CONCLUSION: Our study showed that TORT had less postoperative pain and a greater cosmetic satisfaction than the BABA. There were no significant differences in the postoperative surgical results between the two groups. TORT was comparable to the BABA in outcome with higher cosmetic satisfaction and less pain.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  bilateral axillo-breast approach; comparison; thyroidectomy; transoral

Mesh:

Year:  2018        PMID: 30182367     DOI: 10.1002/jso.25175

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  Postoperative quality of life and cosmetic outcome between minimally invasive video-assisted thyroidectomy and bilateral axillo-breast approach robotic thyroidectomy: a single center retrospective cohort study.

Authors:  Wei-Hsin Chen; Chih-Yi Chen
Journal:  Updates Surg       Date:  2021-03-23

2.  Transoral robotic thyroidectomy versus transoral endoscopic thyroidectomy: a propensity-score-matched analysis of surgical outcomes.

Authors:  Yu-Hsien Chen; Hoon-Yub Kim; Angkoon Anuwong; Ting-Shuo Huang; Quan-Yang Duh
Journal:  Surg Endosc       Date:  2020-10-27       Impact factor: 4.584

3.  The role of carbon nanoparticles in guiding central neck dissection and protecting the parathyroid in transoral vestibular endoscopic thyroidectomy for thyroid cancer.

Authors:  Zhiliang Xu; Yanyan Meng; Junlong Song; Yuan Wang; Xiaoli Yao
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-11-11       Impact factor: 1.195

Review 4.  Working Space Creation in Transoral Thyroidectomy: Pearls and Pitfalls.

Authors:  Tsung-Jung Liang; I-Shu Chen; Shiuh-Inn Liu
Journal:  Cancers (Basel)       Date:  2022-02-17       Impact factor: 6.639

5.  Transoral Thyroidectomy: Advantages and Disadvantages.

Authors:  Wan Wook Kim
Journal:  J Minim Invasive Surg       Date:  2020-09-15

Review 6.  Safety and Efficacy of Transoral Robotic Thyroidectomy for Thyroid Tumor: A Systematic Review and Meta-Analysis.

Authors:  Yun Jin Kang; Jin-Hee Cho; Gulnaz Stybayeva; Se Hwan Hwang
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

7.  A comparison of transoral vestibular and bilateral areolar endoscopic thyroidectomy approaches for unilateral papillary thyroid microcarcinomas.

Authors:  Zhiliang Xu; Junlong Song; Yuan Wang; Lingzhen Tan; Shengrong Sun; Yanyan Meng
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-04-29       Impact factor: 1.195

8.  Quality of life and surgical outcome of ABBA versus EndoCATS endoscopic thyroid surgery: a single center experience.

Authors:  Ulrich Wirth; Thomas von Ahnen; Josef Hampel; Josefine Schardey; Peter Busch; Hans Martin Schardey; Stefan Schopf
Journal:  Surg Endosc       Date:  2021-03-08       Impact factor: 4.584

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.